top of page

Aidsmap, the public value of reliable HIV information

Aidsmap, the public value of reliable HIV information
Aidsmap, the public value of reliable HIV information | Photo: Bret Kavanaugh

Published on 14 June 2026 at 07:15 GMT

By Editorial Team SDG3


Aidsmap, previously known as NAM Aidsmap, is a specialist HIV information service whose public value lies in making complex science on HIV treatment, prevention and care usable for people living with HIV, clinicians, advocates and community organisations. In a field shaped by medical progress, stigma, unequal access and misinformation, reliable public information remains a practical part of health infrastructure, not a secondary concern. The service is now hosted by Terrence Higgins Trust, a UK-based HIV charity, after the former NAM charity faced major funding pressures.

 

The importance of evidence-based HIV information is clear from the scale of the epidemic. UNAIDS estimated that 40.8 million people were living with HIV globally in 2024, while 1.3 million people acquired HIV that year. WHO reported 630,000 HIV-related deaths in 2024, despite major long-term reductions since the epidemic’s peak. These figures show both the success of antiretroviral treatment and the continuing gaps in diagnosis, prevention and care.

 

Aidsmap occupies a specific role in this landscape. It does not deliver clinical care, prescribe treatment or replace medical advice. Its function is to translate research, policy developments and clinical knowledge into accessible material that can help people ask better questions, understand options and follow scientific change. Its own information pages state that its resources are intended to support, rather than replace, consultation with healthcare professionals.

 

That distinction matters. HIV medicine has changed significantly since the 1980s. Effective treatment can allow people with HIV to live long lives and, when viral load is suppressed, prevents sexual transmission. Prevention has also expanded, including condoms, testing, treatment as prevention, pre-exposure prophylaxis and harm reduction. Yet scientific progress does not automatically become public understanding. Information gaps can delay testing, weaken treatment adherence, deepen stigma and leave people vulnerable to poor advice.

 

The organisation’s public-interest contribution is therefore linked to health literacy, a term that is often used narrowly but has wider civic significance. People affected by HIV need information that is accurate enough to be clinically useful, but also clear enough to be understood under stress, after diagnosis, or in settings where stigma makes open discussion difficult. For clinicians, advocates and community workers, accessible summaries of research can support better communication with patients and communities.

 

The history of NAM Aidsmap also reflects the wider history of civil society in the HIV response. HIV activism and community-based knowledge emerged partly because official systems were often slow, under-resourced or mistrusted by those most affected. Community organisations helped make treatment information public, challenged stigma and pushed institutions to respond more urgently. aidsmap belongs to that tradition of HIV public information, while operating in a media environment now shaped by search platforms, social media and fast-moving medical claims.

 

This is a strength, but also a vulnerability. Specialist public-interest information is expensive to produce and difficult to sustain. It requires editors, scientific understanding, fact-checking, conference reporting and independence from commercial pressure. The former NAM charity’s closure showed how fragile such services can be when grant funding, charitable income and public-health budgets tighten. The transfer of aidsmap’s work to Terrence Higgins Trust preserved an important resource, but it also underlined a broader problem: reliable health information often depends on unstable funding.

 

The challenge is not only financial. HIV remains politically sensitive in many contexts because it intersects with sexuality, migration, drug use, poverty, gender inequality and criminalisation. UNAIDS has warned that funding cuts and punitive legal environments can disrupt prevention and care, particularly for key populations. In this context, neutral and accurate information has a protective function, but it cannot overcome legal barriers, discrimination or weak health systems on its own.

 

In Europe, the need for informed public communication remains evident. WHO Europe and the European Centre for Disease Prevention and Control reported 105,922 HIV diagnoses across 49 countries in the WHO European Region in 2024, including 24,164 in the EU/EEA. The data also show significant variation across countries, meaning that public information must speak to different realities, including late diagnosis, migrant health, prevention access and treatment continuity.

 

The work connects most clearly to SDG 3 (good health and well-being), particularly the target of ending AIDS as a public-health threat. That connection should not be overstated. A website or information service cannot by itself deliver testing, medicines or prevention programmes. But without trusted information, biomedical tools are less likely to reach people effectively. The connection to SDG 10 (reduced inequalities) is also relevant, because misinformation and stigma often fall hardest on people already facing social exclusion.

 

Other organisations help form the ecosystem in which aidsmap operates. UNAIDS provides global coordination and data. WHO sets technical guidance and tracks public-health evidence. Terrence Higgins Trust provides services, advocacy and the institutional home for aidsmap. HIV i-Base has long produced treatment information for people living with HIV and clinicians. ECDC contributes surveillance and regional analysis in Europe. Each plays a different role, and none removes the need for independent, accessible public information.

 

A public-interest assessment of Aidsmap should therefore avoid both romanticism and dismissal. Its value is not that information alone solves HIV. It is that accurate HIV resources help people navigate a complicated health issue in which science, policy and lived experience meet. The service’s continuing relevance depends on editorial rigour, transparency about limits, sustainable funding and the ability to reach audiences who may not already be connected to formal HIV services.

 

The future of HIV information will also require adaptation. New medicines, long-acting prevention tools, changing treatment guidelines and debates over global health financing will require careful explanation. At the same time, misinformation can spread quickly, especially where fear and stigma remain. For aidsmap, the central test will be whether it can maintain trust while operating within a changed institutional and financial structure.

 

In practical terms, the organisation’s significance is simple. HIV is now a manageable condition for many people with access to treatment, but unequal access, late diagnosis, stigma and policy failure continue to cost lives. In that gap between scientific possibility and lived reality, trusted HIV information remains essential. Aidsmap matters because it helps keep that information public, understandable and connected to evidence.

 

Further information:

 

Aidsmap, the main HIV information service discussed in this article and now hosted by Terrence Higgins Trust. https://www.aidsmap.com/

 

Terrence Higgins Trust, the UK HIV charity now hosting aidsmap and providing wider HIV and sexual health services. https://www.tht.org.uk/

bottom of page